Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 487.00
+14.00 (2.96%)
Sep 30, 2026, 4:08 PM HKT
HKG:6990 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 151.21 | -381.97 | -266.77 | -574.13 | -616.1 | -889.8 |
Depreciation & Amortization | 109 | 100.4 | 91.39 | 75.08 | 67.36 | 22.91 |
Loss (Gain) From Sale of Assets | 0.12 | 0.12 | 0.15 | 1.49 | -5.42 | 0.01 |
Loss (Gain) From Sale of Investments | -24.13 | -24.13 | -21.55 | -10.53 | -0.51 | -0.36 |
Stock-Based Compensation | 170.7 | 170.7 | 148.29 | 123.35 | 19.81 | 6.5 |
Other Operating Activities | 286.82 | 116.62 | 99.97 | 168.8 | 229.49 | 95.71 |
Change in Accounts Receivable | -41.81 | -41.81 | -88.97 | -124.37 | -20.13 | 0.24 |
Change in Inventory | -130.44 | -130.44 | -47.47 | -10.4 | 26.07 | -37.28 |
Change in Accounts Payable | 271.36 | 271.36 | -50.52 | 252.62 | 50.57 | 90.67 |
Change in Unearned Revenue | -118.91 | -118.91 | -322.68 | 294.34 | 6.2 | 109.04 |
Change in Other Net Operating Assets | -72.16 | -72.16 | 28.4 | -136.67 | -28.2 | 116.42 |
Operating Cash Flow | 531.69 | -180.3 | -429.77 | 59.56 | -270.85 | -485.94 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -110.89 | -125.69 | -77.46 | -80.98 | -33.66 | -94.08 |
Sale of Property, Plant & Equipment | 0 | 0 | 0.03 | 0.01 | 6.33 | - |
Sale (Purchase) of Intangibles | -0.62 | -0.57 | -3.66 | -1.27 | -5.33 | -0.66 |
Investment in Securities | -627.36 | 537.26 | -740.92 | -943.17 | 0.51 | 0.36 |
Investing Cash Flow | -738.87 | 411.01 | -822.01 | -1,025 | -32.15 | -94.38 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 363 | 225.48 |
Total Debt Issued | - | - | - | - | 363 | 225.48 |
Short-Term Debt Repaid | - | - | - | -394.04 | -45 | -70 |
Long-Term Debt Repaid | - | -43.22 | -54.6 | -66.76 | -1.62 | -1.99 |
Lease Payments | -52.14 | -43.22 | -54.6 | -66.76 | -1.62 | -1.99 |
Total Debt Repaid | -52.14 | -43.22 | -54.6 | -460.8 | -46.62 | -71.99 |
Net Debt Issued (Repaid) | -52.14 | -43.22 | -54.6 | -460.8 | 316.38 | 153.49 |
Issuance of Common Stock | - | 1,777 | 1,094 | 2,853 | - | 533.81 |
Other Financing Activities | -7.99 | -6.16 | -2.29 | -10.01 | -2.93 | -39.99 |
Financing Cash Flow | -60.13 | 1,728 | 1,037 | 2,382 | 313.45 | 647.32 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -59.81 | -51.48 | 22.29 | 19.39 | 0.71 | -1.39 |
Net Cash Flow | -327.12 | 1,907 | -192.27 | 1,436 | 11.17 | 65.6 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 420.8 | -305.99 | -507.23 | -21.42 | -304.51 | -580.03 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 20.17% | -14.87% | -26.24% | -1.39% | -37.88% | -1794.52% |
Free Cash Flow Per Share | 1.80 | -1.33 | -2.29 | -0.12 | -3.19 | -6.27 |
Levered Free Cash Flow | 195.4 | -182.09 | -410.8 | -438.58 | -174.83 | - |
Unlevered Free Cash Flow | 198.65 | -178.25 | -408.43 | -385.88 | -81.82 | - |
Free Cash Flow After Leases | 368.66 | -349.2 | -561.83 | -88.19 | -306.13 | -582.02 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 7.99 | 6.16 | 2.29 | 10.01 | 2.93 | 39.99 |
Change in Working Capital | -162.03 | -162.03 | -481.24 | 275.52 | 34.52 | 279.08 |